Recurrence of thin melanoma: How effective is follow-up?

British Journal of Plastic Surgery

Volumn 49, Issue 6, 1996, Pages 409-413

  Moloney, D M ^a,b   Gordon, D J ^a   Briggs, J C ^a   Rigby, H S ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR RECURRENCE;

EID: 0029780383     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0007-1226(96)90012-0     Document Type: Article

References (27)

1. Jensen OM, Bolander AM. Trends in malignant melanoma of the skin. World Health Stat Q 1980; 33: 3-26.
2. Riegel DS. Epidemiology and prognostic factors in malignant melanoma. Ann Plast Surg 1992; 28: 7-8.
3. Heenan PJ, Mulroney CD, Holman CDJ, Armstrong BK. Frequency of thin malignant melanoma. Lancet 1980; ii: 530.
4. Schneider JS, Moore DH, Sagebiel RW. Early diagnosis of cutaneous malignant melanoma at Lawrence Livermore National Laboratory. Arch Dermatol 1990; 126: 767-9.
5. Briggs JC, Ibrahim NBN, Hastings AG, Griffiths RW. Experience of thin cutaneous melanomas (<0.76 mm and 0.85 mm) in a large plastic surgery unit: a 5 to 17 year follow-up. Br J Plast Surg 1984; 37: 501-6.
6. Sondegaard K. The intralesional variation of type, level of invasion and tumour thickness of primary cutaneous malignant melanoma. Acta Pathol Microbiol 1980; 88 (Section A): 269-74.
7. Breslow A. Thickness, cross-sectional area and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902-8.
8. Breslow A. Prognostic factors in the treatment of cutaneous malignant melanoma. J Cutan Pathol 1979; 6: 208-11.
9. Woods JE, Soule EH, Creagan ET. Metastasis and death in patients with thin melanomas (less than 0.76 mm). Ann Surg 1983; 198: 63-4.
10. Naruns PL, Nizze JA, Cochran AJ, Lee MB, Morton DL. Recurrence potential of thin primary melanomas. Cancer 1986; 57: 545-8.
11. Slingluff CL, Vollmer RT, Reintgen DS, Seigler HF. Lethal thin malignant melanoma. Ann Surg 1988; 208: 150-61.
12. Shaw HM, Rivers JK, McCarthy SW, McCarthy WH. Cutaneous melanomas exhibiting unusual biologic behaviour. World J Surg 1992; 16: 196-202.
13. Slingluff CL, Dodge RK, Stanley WE, Seigler HF. The annual risk of melanoma progression. Cancer 1992; 70: 1917-27.
14. McCarthy WH, Shaw HM, Thompson JF, Milton GW. Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study. Surg Gynecol Obstet 1988; 166: 497-502.
15. Romero JB, Stefanato CM, Kopf AW, Bart RS. Follow-up recommendations for patients with stage I malignant melanoma. J Dermatol Surg Oncol 1994; 20: 175-8.
16. Regan MW, Reid CD, Griffiths RW, Briggs JC. Malignant melanoma, evaluation of clinical follow up by questionnaire survey. Br J Plast Surg 1985; 38: 11-14.
17. Bird DL, Fox JN, Ashley S, Imrie MJ. Results of the first year of breast cancer screening in a district hospital. Br J Surg 1992; 79: 922-4.
18. Atkin WS, Cuzick J, Northover JMA, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 1993; 341: 736-40.
19. Benoit RM, Naslund MJ. An economic rationale for prostate cancer screening. Urology 1994; 44: 795-803.
20. Gupta BK, Piedmonte MR, Karakousis CP. Attributes and survival patterns of multiple primary cutaneous malignant melanoma. Cancer 1992; 67: 1984-9.
21. Slingluff CL, Vollmer RT, Seigler HF. Multiple primary melanoma incidence and risk factors in 283 patients. Surgery 1993; 113: 330-9.
22. Jatoi I, Baum M. American and European recommendations for screening mammography in younger women: a cultural divide. BMJ 1993; 307: 1481-3.
23. Day CL, Mihm MC, Sober AJ, et al. Prognostic factors for melanoma patients with lesions 0.76-1.69 mm in thickness. Ann Surg 1992; 195: 30-4.
24. Kelly JW, Sagebiel RW, Clyman S, Blois MS. Thin level IV malignant melanoma: a subset in which level is the major prognostic indicator. Ann Surg 1985; 202: 98-103.
25. Balch CM, Soong SJ, Mirad TM, Ingalls AL, Madox WA. A multifactorial analysis of melanoma: II. Prognostic factors in patients with stage I (localised) melanoma. Surgery 1979; 86: 343-50.
26. Paladugu RR, Yonemoto RH. Biologic behaviour of thin malignant melanomas with regressive change. Arch Surg 1983; 118: 41-4.
27. Sondegaard K, Hou-Jensen K. Partial regression in thin primary cutaneous melanomas, clinical stage I: a study of 486 cases. Virchow's Arch 1985; 408: 241-7.